Genetic modifiers and subtypes in schizophrenia: Investigations of age at onset, severity, sex and family history

Schizophrenia Research

Volumn 154, Issue 1-3, 2014, Pages 48-53

  Bergen, Sarah E ^a,b,k   O'Dushlaine, Colm T ^b   Lee, Phil H ^a,b   Fanous, Ayman H ^c,d,e,f,g   Ruderfer, Douglas M ^a,h   Ripke, Stephan ^a,b   Sullivan, Patrick F ^j   Smoller, Jordan W ^a   Purcell, Shaun M ^a,h   Corvin, Aiden ⁱ  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ TRINITY COLLEGE DUBLIN   (Ireland)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Association; Gender; GWAS; Psychosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; KIF5C GENE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OR2K2 GENE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; ST18 GENE; ADOLESCENT; CHILD; FAMILY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PHENOTYPE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 84897020235     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.030     Document Type: Article

References (44)

1. American Psychiatric Association Diagnostic Criteria From DSM-IV-TR 2000, American Psychiatric Association, Washington, D.C.
2. Angermeyer M.C., Kuhn L. Gender differences in age at onset of schizophrenia. An overview. Eur. Arch. Psychiatry Neurol. Sci. 1988, 237(6):351-364.
3. Bergen S.E., Petryshen T.L. Genome-wide association studies of schizophrenia: does bigger lead to better results?. Curr. Opin. Psychiatry 2012, 25(2):76-82.
4. Bergen S.E., O'Dushlaine C.T., Ripke S., Lee P.H., Ruderfer D.M., Akterin S., Moran J.L., Chambert K.D., Handsaker R.E., Backlund L., Osby U., McCarroll S., Landen M., Scolnick E.M., Magnusson P.K., Lichtenstein P., Hultman C.M., Purcell S.M., Sklar P., Sullivan P.F. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol. Psychiatry 2012, 17:880-886.
5. Beyer K., Lao J.I., Latorre P., Ariza A. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Ann. N. Y. Acad. Sci. 2005, 1057:260-278.
6. Browning S.R., Browning B.L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 2007, 81(5):1084-1097.
7. Campbell D.B., Lange L.A., Skelly T., Lieberman J., Levitt P., Sullivan P.F. Association of RGS2 and RGS5 variants with schizophrenia symptom severity. Schizophr. Res. 2008, 101(1-3):67-75.
8. Chen L., Hsu L., Malone K. A frailty-model-based approach to estimating the age-dependent penetrance function of candidate genes using population-based case-control study designs: an application to data on the BRCA1 gene. Biometrics 2009, 65(4):1105-1114.
9. Cohen R.Z., Seeman M.V., Gotowiec A., Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. Am. J. Psychiatry 1999, 156(7):1059-1064.
10. International Schizophrenia Consortium, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
11. Esterberg M.L., Trotman H.D., Holtzman C., Compton M.T., Walker E.F. The impact of a family history of psychosis on age-at-onset and positive and negative symptoms of schizophrenia: a meta-analysis. Schizophr. Res. 2010, 120(1-3):121-130.
12. Fanous A.H., Kendler K.S. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol. Psychiatry 2005, 10(1):6-13.
13. Gorwood P., Leboyer M., Jay M., Payan C., Feingold J. Gender and age at onset in schizophrenia: impact of family history. Am. J. Psychiatry 1995, 152(2):208-212.
14. Hafner H., Maurer K., Loffler W., Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry 1993, 162(1):80-86.
15. Hare E., Glahn D.C., Dassori A., Raventos H., Nicolini H., Ontiveros A., Medina R., Mendoza R., Jerez A., Munoz R., Almasy L., Escamilla M.A. Heritability of age of onset of psychosis in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(1):298-302.
16. Hingson R.W., Heeren T., Winter M.R. Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch. Pediatr. Adolesc. Med. 2006, 160(7):739-746.
17. International HapMap Consortium, Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., Pasternak S., Wheeler D.A., Willis T.D., Yu F., Yang H., Zeng C., Gao Y., Hu H., Hu W., Li C., Lin W., Liu S., Pan H., Tang X., Wang J., Wang W., Yu J., Zhang B., Zhang Q., Zhao H., Zhao H., Zhou J., Gabriel S.B., Barry R., Blumenstiel B., Camargo A., Defelice M., Faggart M., Goyette M., Gupta S., Moore J., Nguyen H., Onofrio R.C., Parkin M., Roy J., Stahl E., Winchester E., Ziaugra L., Altshuler D., Shen Y., Yao Z., Huang W., Chu X., He Y., Jin L., Liu Y., Shen Y., Sun W., Wang H., Wang Y., Wang Y., Xiong X., Xu L., Waye M.M., Tsui S.K., Xue H., Wong J.T., Galver L.M., Fan J.B., Gunderson K., Murray S.S., Oliphant A.R., Chee M.S., Montpetit A., Chagnon F., Ferretti V., Leboeuf M., Olivier J.F., Phillips M.S., Roumy S., Sallee C., Verner A., Hudson T.J., Kwok P.Y., Cai D., Koboldt D.C., Miller R.D., Pawlikowska L., Taillon-Miller P., Xiao M., Tsui L.C., Mak W., Song Y.Q., Tam P.K., Nakamura Y., Kawaguchi T., Kitamoto T., Morizono T., Nagashima A., Ohnishi Y., Sekine A., Tanaka T., Tsunoda T., Deloukas P., Bird C.P., Delgado M., Dermitzakis E.T., Gwilliam R., Hunt S., Morrison J., Powell D., Stranger B.E., Whittaker P., Bentley D.R., Daly M.J., de Bakker P.I., Barrett J., Chretien Y.R., Maller J., McCarroll S., Patterson N., Pe'er I., Price A., Purcell S., Richter D.J., Sabeti P., Saxena R., Schaffner S.F., Sham P.C., Varilly P., Altshuler D., Stein L.D., Krishnan L., Smith A.V., Tello-Ruiz M.K., Thorisson G.A., Chakravarti A., Chen P.E., Cutler D.J., Kashuk C.S., Lin S., Abecasis G.R., Guan W., Li Y., Munro H.M., Qin Z.S., Thomas D.J., McVean G., Auton A., Bottolo L., Cardin N., Eyheramendy S., Freeman C., Marchini J., Myers S., Spencer C., Stephens M., Donnelly P., Cardon L.R., Clarke G., Evans D.M., Morris A.P., Weir B.S., Tsunoda T., Mullikin J.C., Sherry S.T., Feolo M., Skol A., Zhang H., Zeng C., Zhao H., Matsuda I., Fukushima Y., Macer D.R., Suda E., Rotimi C.N., Adebamowo C.A., Ajayi I., Aniagwu T., Marshall P.A., Nkwodimmah C., Royal C.D., Leppert M.F., Dixon M., Peiffer A., Qiu R., Kent A., Kato K., Niikawa N., Adewole I.F., Knoppers B.M., Foster M.W., Clayton E.W., Watkin J., Gibbs R.A., Belmont J.W., Muzny D., Nazareth L., Sodergren E., Weinstock G.M., Wheeler D.A., Yakub I., Gabriel S.B., Onofrio R.C., Richter D.J., Ziaugra L., Birren B.W., Daly M.J., Altshuler D., Wilson R.K., Fulton L.L., Rogers J., Burton J., Carter N.P., Clee C.M., Griffiths M., Jones M.C., McLay K., Plumb R.W., Ross M.T., Sims S.K., Willey D.L., Chen Z., Han H., Kang L., Godbout M., Wallenburg J.C., L'Archeveque P., Bellemare G., Saeki K., Wang H., An D., Fu H., Li Q., Wang Z., Wang R., Holden A.L., Brooks L.D., McEwen J.E., Guyer M.S., Wang V.O., Peterson J.L., Shi M., Spiegel J., Sung L.M., Zacharia L.F., Collins F.S., Kennedy K., Jamieson R., Stewart J. A second generation human haplotype map of over 3.1million SNPs. Nature 2007, 449(7164):851-861.
18. International Schizophrenia Consortium Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455(7210):237-241.
19. Janca A., Ustun T.B., Early T.S., Sartorius N. The ICD-10 symptom checklist: a companion to the ICD-10 classification of mental and behavioural disorders. Soc. Psychiatry Psychiatr. Epidemiol. 1993, 28(5):239-242.
20. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24(24):2938-2939.
21. Kantojarvi K., Onkamo P., Vanhala R., Alen R., Hedman M., Sajantila A., Nieminen-von Wendt T., Jarvela I. Analysis of 9p24 and 11p12-13 regions in autism spectrum disorders: rs1340513 in the JMJD2C gene is associated with ASDs in Finnish sample. Psychiatr. Genet. 2010, 20(3):102-108.
22. Kendler K.S. Sporadic vs familial classification given etiologic heterogeneity: I. Sensitivity, specificity, and positive and negative predictive value. Genet. Epidemiol. 1987, 4(5):313-330.
23. Korn J.M., Kuruvilla F.G., McCarroll S.A., Wysoker A., Nemesh J., Cawley S., Hubbell E., Veitch J., Collins P.J., Darvishi K., Lee C., Nizzari M.M., Gabriel S.B., Purcell S., Daly M.J., Altshuler D. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 2008, 40(10):1253-1260.
24. Lee P.H., O'Dushlaine C., Thomas B., Purcell S.M. INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 2012, 28(13):1797-1799.
25. Leverich G.S., Post R.M., Keck P.E., Altshuler L.L., Frye M.A., Kupka R.W., Nolen W.A., Suppes T., McElroy S.L., Grunze H., Denicoff K., Moravec M.K., Luckenbaugh D. The poor prognosis of childhood-onset bipolar disorder. J. Pediatr. 2007, 150(5):485-490.
26. Lewine R.R. Sex differences in age of symptom onset and first hospitalization in schizophrenia. Am. J. Orthopsychiatry 1980, 50(2):316-322.
27. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
28. Lips E.S., Cornelisse L.N., Toonen R.F., Min J.L., Hultman C.M., the International Schizophrenia C, Holmans P.A., O'Donovan M.C., Purcell S.M., Smit A.B., Verhage M., Sullivan P.F., Visscher P.M., Posthuma D. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol. Psychiatry 2012, 17(10):996-1006.
29. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 1991, 48(8):764-770.
30. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
31. Rabinowitz J., Levine S.Z., Hafner H. A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophr. Res. 2006, 88(1-3):96-101.
32. Rees E., Moskvina V., Owen M.J., O'Donovan M.C., Kirov G. De novo rates and selection of schizophrenia-associated copy number variants. Biol. Psychiatry 2011, 70(12):1109-1114.
33. R Development Core Team R: a Language and Environment for Statistical Computing 2012, R Foundation for Statistical Computing, Vienna, Austria.
34. Schizophrenia Psychiatric Genome-Wide Association Study Consortium Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
35. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60(12):1187-1192.
36. Taylor S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin. Psychol. Rev. 2011, 31(7):1083-1100.
37. Wang K.S., Liu X., Zhang Q., Aragam N., Pan Y. Genome-wide association analysis of age at onset in schizophrenia in a European-American sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011, 156B(6):671-680.
38. Webb R., Kelly J.A., Somers E.C., Hughes T., Kaufman K.M., Sanchez E., Nath S.K., Bruner G., Alarcon-Riquelme M.E., Gilkeson G.S., Kamen D.L., Richardson B.C., Harley J.B., Sawalha A.H. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann. Rheum. Dis. 2011, 70(1):151-156.
39. Williams J., Farmer A.E., Ackenheil M., Kaufmann C.A., McGuffin P. A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system. Psychol. Med. 1996, 26(4):775-783.
40. Wissmann M., Yin N., Muller J.M., Greschik H., Fodor B.D., Jenuwein T., Vogler C., Schneider R., Gunther T., Buettner R., Metzger E., Schule R. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol. 2007, 9(3):347-353.
41. Wright G.E., Niehaus D.J., van der Merwe L., Koen L., Korkie L.J., Kinnear C.J., Drogemoller B.I., Warnich L. Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39(1):163-169.
42. Xu B., Roos J.L., Dexheimer P., Boone B., Plummer B., Levy S., Gogos J.A., Karayiorgou M. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat. Genet. 2011, 43(9):864-868.
43. Yang J., Siqueira M.F., Behl Y., Alikhani M., Graves D.T. The transcription factor ST18 regulates proapoptotic and proinflammatory gene expression in fibroblasts. FASEB J. 2008, 22(11):3956-3967.
44. Yang J., Visscher P.M., Wray N.R. Sporadic cases are the norm for complex disease. Eur. J. Hum. Genet. 2010, 18(9):1039-1043.